# YUPELRI
> **NDA210598** · New Drug Application · Sponsor: MYLAN IRELAND LTD · Approved 2018-11-09
## Drug
- **FDA Application Number:** NDA210598
- **Application type:** New Drug Application
- **Brand name:** YUPELRI
- **Generic name:** REVEFENACIN
- **Active ingredients:** REVEFENACIN
- **Dosage form:** SOLUTION
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** MYLAN IRELAND LTD
- **Manufacturer:** Viatris Specialty LLC
- **First approval:** 2018-11-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210598)
---
*MORVS · CC0 1.0*